Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
|
|
CLS Holdings USA, Inc. (CLSH)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/12/2023 |
10-Q
| Quarterly Report for the period ended August 31, 2023 |
| 10/04/2023 |
10-K/A
| Annual Report for the period ended May 31, 2023 [amend] |
| 08/24/2023 |
10-K
| Annual Report for the period ended May 31, 2023 |
| 04/13/2023 |
8-K
| Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits Interactive Data |
| 03/07/2023 |
8-K
| Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of... |
| 01/17/2023 |
8-K
| Quarterly results |
| 01/12/2023 |
8-K
| Quarterly results |
| 01/12/2023 |
10-Q
| Quarterly Report for the period ended November 30, 2022 |
| 11/22/2022 |
8-K
| Quarterly results |
| 10/14/2022 |
SC 13G
| Tribeca Investment Partners Pty Ltd reports a 18.2% stake in CLS Holdings USA, Inc. |
| 10/13/2022 |
10-Q
| Quarterly Report for the period ended August 31, 2022 |
| 09/30/2022 |
SC 13D/A
| Navy Capital Green Management LLC reports a 51.6% stake in 1 CLS Holdings USA, Inc. |
| 09/30/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 09/30/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 09/21/2022 |
8-K
| Entry into a Material Definitive Agreement, Material Modifications to Rights of Security Holders, Amendments to Articles of I...|
Docs:
|
"Certificate of Change filed September 19, 2022 effective September 21, 2022",
"Supplemental Indenture to Debenture Indenture dated December 12, 2018, as supplemented on March 31, 2021, by and between the Company and Odyssey Trust Company",
"Supplemental Indenture to Warrant Indenture dated December 12, 2018, as supplemented on March 31, 2021, by and between the Company and Odyssey Trust Company",
"Second Amendment to Subscription Agreement, by CLS Holdings USA, Inc., in favor Navy Capital Green Fund, LP",
"Second Amendment to Subscription Agreement, by CLS Holdings USA, Inc., in favor Navy Capital Green Co-Invest Fund, LLC",
"Second Amended and Restated Convertible Debenture, issued to Navy Capital Green Fund, LP",
"Second Amended and Restated Convertible Debenture, issued to Navy Capital Green Co-Invest Fund, LLC",
"Form of Warrant" |
|
| 08/25/2022 |
10-K
| Annual Report for the period ended May 31, 2022 |
| 08/22/2022 |
8-K
| Quarterly results |
| 08/18/2022 |
8-K
| Quarterly results |
| 06/07/2022 |
RW
| Form RW - Registration Withdrawal Request: |
| 06/02/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 05/23/2022 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
| 05/11/2022 |
8-K
| Quarterly results |
| 04/28/2022 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
| 04/14/2022 |
8-K
| Investor presentation|
Docs:
|
"Investor Presentation dated April 2022",
"CLS Holdings USA, Inc to Host Q3, 2022 Financial Results on April 14, 2022 LAS VEGAS, April 5, 2022 –- CLS Holdings USA, Inc. , the “Company” or “CLS”, a diversified cannabis company operating as Cannabis Life Sciences, will host a webcast on Thursday, April 14, 2022 at 5 p.m. ET to discuss the Company's financial highlights for its third quarter of fiscal year 2022. Event: CLS Holdings USA, Inc. Q3 FY 2022 Financial Results Webcast Date: Thursday, April 14, 2022 Time: 5:00 p.m. Eastern Time Webcast: https://onlinexperiences.com/Launch/QReg/ShowUUID=E795A5B4-8436-4A51-BD49-1BE65CB39778&LangLocaleID=1033&GroupID=Onyx For interested individuals unable to join the webcast, a replay of the webcast will be available on the CLS Holdings USA, Inc., website and can be accessed by visiting https://..." |
|
| 04/14/2022 |
10-Q
| Quarterly Report for the period ended February 28, 2022 |
| 04/08/2022 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
| 03/15/2022 |
8-K
| Regulation FD Disclosure Interactive Data |
| 02/14/2022 |
SC 13G/A
| SWANSON TODD V reports a 10.2% stake in CLS Holdings USA, Inc. |
| 01/12/2022 |
10-Q
| Quarterly Report for the period ended November 30, 2021 |
| 12/23/2021 |
D
| Form D - Notice of Exempt Offering of Securities: |
| 11/22/2021 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 10/26/2021 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
| 10/12/2021 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data|
Docs:
|
"A Positive Outlook : CLS Holdings USA, Inc. Reports Its First Ever Profitable Quarter with latest 10Q Results LAS VEGAS, NV October 12, 2021 -- CLS Holdings USA, Inc. , the ''Company'' or ''CLS'', a diversified cannabis company operating as Cannabis Life Sciences, today announced its operational and financial results for the first quarter of fiscal 2022, ended August 31, 2021. Key Q1 Financial & Operational Accomplishments ● The Company achieved a positive net profit for the first time in its history, making it the most profitable quarter to date ● Net income for the quarter ended August 31, 2021 was $427,599, Net loss for the quarter ended August 31, 2020 was ● Revenue growth proved to be significant with an increase of 45.5% compared to last year’s Q1 numbers ● Th..." |
|
| 10/12/2021 |
10-Q
| Quarterly Report for the period ended August 31, 2021 |
|
|
|